Skip to content
  • Saturday, 12 September 2026
  • 7:04 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Pharmaceutical R&D

Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach

Teuku Ryan Apr 9, 2026 0

Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…

Read More
Pharmaceutical R&D

HNSCC market is expected to reach to $4.5bn across 8MM by 2034 – Pharmaceutical Technology

Teuku Ryan Apr 2, 2026 0

The global market for head and neck squamous cell carcinoma (HNSCC) therapeutics is poised for significant expansion, with projections indicating…

Read More
Koala Resilience: Rapid Population Growth Offers Hope for Genetic Recovery After Severe BottlenecksNigerian Researchers Unveil Water-in-Diesel Emulsion Technology as a Sustainable Path to Reducing Global Engine EmissionsEli Lilly’s Retatrutide Achieves Unprecedented Weight Loss in TRIUMPH-1 Trial, Signaling New Era in Obesity PharmacotherapyIonis Forecasts $2 Billion Peak Sales for Tryngolza, Leveraging First-Mover Advantage in Severe Hypertriglyceridemia
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease ResearchA novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative diseaseThe oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease Research
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ